Edition:
United States

People: GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,467.00GBp
2 Dec 2016
Change (% chg)

-1.50p (-0.10%)
Prev Close
1,468.50p
Open
1,462.00p
Day's High
1,471.50p
Day's Low
1,452.00p
Volume
6,542,323
Avg. Vol
9,198,998
52-wk High
1,745.56p
52-wk Low
1,259.32p

Elsenhans, Lynn 

Ms. Lynn Laverty Elsenhans is Non-Executive Independent Director of GlaxoSmithKline Plc., since 1 July 2012. She has a wealth of experience of running a global business and significant knowledge of the global markets in which GSK operates. She served as Chair, President and Chief Executive Officer of Sunoco Inc. from 2009 to 2012. Prior to joining Sunoco in 2008 as President and Chief Executive Officer, Lynn worked for Royal Dutch Shell which she joined in 1980 and where she held a number of senior roles, including Executive Vice President, Global Manufacturing from 2005 to 2008. External appointments Lynn is a Non-Executive Director of Baker Hughes Inc. and Flowserve Corporation, a Director of the Texas Medical Center, and a Non-Executive Director of The First Tee of Greater Houston. She is also a Trustee of the United Way of Greater Houston.

Basic Compensation

Total Annual Compensation, GBP 136,000
Restricted Stock Awards, GBP --
Long-Term Incentive Plans, GBP --
All Other, GBP 63,000
Fiscal Year Total, GBP 199,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Philip Hampton

522,000

Andrew Witty

6,661,000

Simon Dingemans

3,166,000

Moncef Slaoui

7,324,000

Roger Connor

--

Abbas Hussain

--
As Of  30 Dec 2015